tradingkey.logo
搜尋

Twist Bioscience Corp

TWST
添加自選
99.240USD
-3.010-2.94%
收盤 07/02, 13:00美東報價延遲15分鐘
6.17B總市值
虧損本益比TTM

關於 Twist Bioscience Corp 公司

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp簡介

公司代碼TWST
公司名稱Twist Bioscience Corp
上市日期Oct 31, 2018
CEOLeproust (Emily M)
員工數量979
證券類型Ordinary Share
年結日Oct 31
公司地址681 Gateway Blvd.
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94080
電話18007190671
網址https://www.twistbioscience.com/
公司代碼TWST
上市日期Oct 31, 2018
CEOLeproust (Emily M)

Twist Bioscience Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.75K
-16.90%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
7.12K
-84.57%
Ms. Trynka Shineman Blake
Ms. Trynka Shineman Blake
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%

常見問題

Twist Bioscience Corp的前五大股東是誰?

Twist Bioscience Corp的前五大股東如下:Dr. Emily M. Leproust, Ph.D.

有多少機構持有Twist Bioscience Corp(TWST)的股份?

截至2026Q1,共有592家機構持有Twist Bioscience Corp的股份,合計持有的股份價值約為78.48M,占公司總股份的126.03% 。與2025Q4相比,機構持股有所增加,增幅為-339291.00。

哪個業務部門對Twist Bioscience Corp的收入貢獻最大?

在2026Q1,NGS applications業務部門對Twist Bioscience Corp的收入貢獻最大,創收52.64M,占總收入的50.76% 。